IN8bio, Inc.
INAB
$1.80
-$0.11-5.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.77% | 45.61% | 40.97% | 35.18% | 18.93% |
| Total Depreciation and Amortization | -25.78% | -23.62% | 24.25% | 5.85% | 11.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.82% | -61.75% | -18.45% | -32.98% | -34.11% |
| Change in Net Operating Assets | 159.67% | 41.67% | -177.72% | 175.51% | -30.38% |
| Cash from Operations | 46.90% | 42.33% | 35.53% | 60.58% | 16.95% |
| Capital Expenditure | -- | -- | -- | -- | 54.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 54.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 49.32% | 42.25% | -34.48% | -19.68% | -26.59% |
| Issuance of Common Stock | 65.70% | 284.78% | 54.83% | -- | -17.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 65.27% | 1,041.90% | 55.87% | 1,505.42% | -16.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129.44% | 59.22% | 147.94% | 109.33% | -15.47% |